Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Helen of Troy
HELE
$691M
| $899K | ﹤0.01% |
8,110
+981
| +14% | +$95.5K |
|
2827
Kiniksa Pharmaceuticals
KNSA
$6.06B
| $899K | ﹤0.01% |
60,007
+37,666
| +169% | +$548K |
|
2828
First Merchants
FRME
$2.73B
| $898K | ﹤0.01% |
21,844
+16,444
| +305% | +$695K |
|
2829
Ocular Therapeutix
OCUL
$1.88B
| $896K | ﹤0.01% |
318,834
+315,567
| +9,659% | +$1.04M |
|
2830
Pathward Financial
CASH
$1.89B
| $895K | ﹤0.01% |
20,794
+8,157
| +65% | +$335K |
|
2831
CALL
Prudential Financial
PRU
$41.7B
| $895K | ﹤0.01% |
9,000
| – | – |
|
2832
CALL
QuantumScape Corp
QS
$3.38B
| $894K | ﹤0.01% |
+157,600
| New | +$1.17M |
|
2833
MGP Ingredients
MGPI
$376M
| $891K | ﹤0.01% |
8,380
+2,266
| +37% | +$253K |
|
|
EVOP
2834
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $891K | ﹤0.01% |
26,316
+10,711
| +69% | +$360K |
|
|
RCM
2835
DELISTED
R1 RCM Inc. Common Stock
RCM
| $890K | ﹤0.01% |
81,293
+72,432
| +817% | +$920K |
|
2836
First Commonwealth Financial
FCF
$2.2B
| $890K | ﹤0.01% |
63,705
+24,627
| +63% | +$347K |
|
2837
Patrick Industries
PATK
$2.92B
| $889K | ﹤0.01% |
22,011
-2,860
| -11% | -$99.5K |
|
2838
BOK Financial
BOKF
$8.8B
| $888K | ﹤0.01% |
8,558
-775
| -8% | -$78.6K |
|
|
TUYA
2839
Tuya Inc
TUYA
$1.07B
| $887K | ﹤0.01% |
464,172
-78,000
| -14% | -$94.7K |
|
2840
Adicet Bio
ACET
$85.2M
| $882K | ﹤0.01% |
6,166
+1,016
| +20% | +$254K |
|
|
HUYA
2841
Huya Inc
HUYA
$561M
| $880K | ﹤0.01% |
222,891
+2,416
| +1% | +$6.12K |
|
2842
MacroGenics
MGNX
$248M
| $878K | ﹤0.01% |
130,921
+69,866
| +114% | +$383K |
|
2843
Carpenter Technology
CRS
$28.6B
| $878K | ﹤0.01% |
23,768
+10,519
| +79% | +$401K |
|
|
NUVL
2844
DELISTED
Nuvalent
NUVL
| $877K | ﹤0.01% |
29,438
+28,721
| +4,006% | +$801K |
|
2845
SentinelOne
S
$7.25B
| $876K | ﹤0.01% |
60,024
-265,928
| -82% | -$4.92M |
|
2846
Sylvamo
SLVM
$1.56B
| $876K | ﹤0.01% |
18,023
-9,778
| -35% | -$469K |
|
|
GDEN
2847
DELISTED
Golden Entertainment
GDEN
| $876K | ﹤0.01% |
23,411
+5,489
| +31% | +$226K |
|
2848
Gentex
GNTX
$5.13B
| $875K | ﹤0.01% |
32,093
-47,618
| -60% | -$1.27M |
|
2849
CALL
Affirm
AFRM
$26.3B
| $875K | ﹤0.01% |
+90,500
| New | +$1.36M |
|
2850
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.88B
| $875K | ﹤0.01% |
30,189
+17,489
| +138% | +$509K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.